5-HT Receptor Mechanisms in Human Anxiety

  • J. F. W. Deakin
  • F. S. Guimarães
  • M. Wang
  • J. Hellewell
  • R. Hensman
Chapter

Abstract

5-HT has been implicated in the mechanisms of anxiety since the seminal studies of Graeff and Schoenfeld (1970) and Geller and Blum (1970). They showed that 5-HT receptor antagonists and inhibition of 5-HT synthesis prevented the ability of foot shock to suppress operant behaviour. The subsequent observation that the anxiolytic benzodiazepine oxazepam decreased 5-HT turnover lead to the suggestion that anxiolytic drugs work by inhibition of 5-HT function (Wise et al., 1972).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bolles, R. C. and Fanselow, M. S. (1980). A perceptual—defensive—recuperative model of fear and pain. Behav. Brain Sci., 3, 291–323.CrossRefGoogle Scholar
  2. Campbell, D., Sanderson, R. E. and Laverty, S. G. (1964). Characteristics of a conditioned response in human subjects during extinction trials following a single traumatic conditioning trial. J. Abn. Soc. Psychol., 6, 627–39.CrossRefGoogle Scholar
  3. Chapman, W. P., Shroeder, H. R., Geyer, G., Brazier, M. A. B., Fanger, C., Poppen, J. S., Solomon, H. C. and Iakolev, P. I. (1954). Physiological evidence concerning importance of the amygdaloid nuclear regions in the circulatory function and emotion in man. Science, 120, 949–50.PubMedCrossRefGoogle Scholar
  4. Crow, T. J. (1973). Catecholamine-neurones and self-stimulation. II: A theoretical interpretation and some psychiatry implications. Psychol. Med., 3, 66–73.PubMedCrossRefGoogle Scholar
  5. Crow, T. J. and Deakin, J. F. W. (1978). Brain reinforcement centres and psychoactive drugs. In Israel, Y., Glaser, F. B., Kalant, H., Popham, R. E., Schmidt, W. and Smart, R. G. (eds.), Recent Advances in Alcohol and Drug Problems, Plenum, New York, 25–76.CrossRefGoogle Scholar
  6. Davies, M. (1989). The role of the amygdaloid and its efferent projections in fear and anxiety. In Tryer, P. (ed.), Psychopharmacology of Anxiety, Oxford University Press, Oxford, 52–79.Google Scholar
  7. Deakin, J. F. W. (1983). Roles of serotonergic systems in escape, avoidance and other behaviours. In Cooper, S. J. (ed.), Theory in Psychopharmacology, vol. 2, Academic Press, New York, 149–93.Google Scholar
  8. Deakin, J. F. W. (1988). 5-HT2 receptors, depression and anxiety. Pharmacol. Biochem. Behav., 29, 819–20.PubMedCrossRefGoogle Scholar
  9. Deakin, J. F. W. (1990). Serotonin subtypes and affective disorder. In Idzikowski, C. and Cowen, P. (eds.), Serotonin, Sleep and Mental Disorder, Blackwell Scientific Publications (in press).Google Scholar
  10. Deakin, J. F. W., Pennell, I., Upadhyaya, A. J. and Lofthouse, R. (1990). A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology, 101, 85–92.PubMedCrossRefGoogle Scholar
  11. Den Boer, J. A. (1988). Serotonergic Mechanisms in Anxiety Disorders. An Inquiry into Serotonin Function in Panic Disorder. Rijksuniversieteit te Utrecht, Utrecht.Google Scholar
  12. Den Boer, J. A. and Westenberg, H. G. M. (1988). Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. Int. Clin. Psychopharmacol., 3, 59–74.PubMedCrossRefGoogle Scholar
  13. Geller, I. and Blum, K. (1970). The effects of 5-HTP on parachlorophenylalanine (P-CPA) attenuation of conflict behavior. Europ. J. Pharmacol., 9, 319–24.CrossRefGoogle Scholar
  14. Goa, K. L. and Ward, A. (1986). Buspirone, a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs, 32, 114–29.PubMedCrossRefGoogle Scholar
  15. Goldberg, H. L. and Finnerty, R. J. (1979). The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry, 136, 1184–7.PubMedCrossRefGoogle Scholar
  16. Graeff, F. G. (1989). Serotonin and aversion. In Bevan, P., Cools, A. R. and Archer, T. (eds.), Behavioural Pharmacology of 5HT, Lawrence Erlbaum, London, 425–43.Google Scholar
  17. Graeff, F. G. and Schoenfeld, R. I. (1970). Tryptaminergic mechanisms in punished and nonpunished behaviour. J. Pharmacol. Exp. Ther., 173, 277–83.PubMedGoogle Scholar
  18. Gray, J. A. (1982). The Neuropsychology of Anxiety, Oxford University Press, Oxford.Google Scholar
  19. Gray, J. A. (1987). The Psychology of Fear and Stress, 2nd edn, Cambridge University Press, Cambridge.Google Scholar
  20. Guimaraes, F. S., Hellewell, J., Wang, M. and Deakin, J. F. W. (1990). Sex difference in aversive classical conditioning and responsiveness to anxiolytic drugs in humans. Br. J. Clin. Pharmacol., 29, 141P–142P.Google Scholar
  21. Guimaraes, F. S., Zuardi, A. W. and Graeff, F. G. (1987). Effect of chlorimipramine and maprotiline on experimental anxiety in humans. J. Psychopharmacol., 1, 184–92.PubMedCrossRefGoogle Scholar
  22. Hellewell, J., Hensman, R., Guimaraes, F. and Deakin, J. F. W. (1989). Effect of 5HT-active drugs on aversive conditioning in healthy volunteers. J. Psychopharmacol., 3, 111P.Google Scholar
  23. Hodges, H., Green, S. and Glenn, B. (1987). Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology, 92, 491–504.PubMedCrossRefGoogle Scholar
  24. Johnston, D. G., Troyer, I. E. and Whitsett, S. F. (1988). Clomipramine treatment of agoraphobic women. Arch. Gen. Psychiatry, 45, 453–9.PubMedCrossRefGoogle Scholar
  25. Johnstone, E. C., Owens, D. G. C., Frith, C. D., McPherson, K., Dowie, C., Riley, G. and Gold, A. (1980). Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychological Med., 10, 321–8.CrossRefGoogle Scholar
  26. Kahn, R. J., McNair, D. M., Lipman, R. S., Covi, L., Rickels, K., Downing, R., Fisher, S. and Frankenthaler, L. M. (1986). Imipramine and chlordiazepoxide in depressive and anxiety disorders. II: Efficacy in anxious outpatients. Arch. Gen. Psychiatry, 43, 79–85.PubMedCrossRefGoogle Scholar
  27. Kataoka, Y., Schibata, K., Tamashita, K. and Ueki, S. (1987). Differential mechanisms involved in the anticonflict action of benzodiazepines injected into the central amygdala and mammillary body. Brain Res., 416, 243–7.PubMedCrossRefGoogle Scholar
  28. Kiser, R. S., Brown, C. A., Sanghera, M. K. and German, D. C. (1980). Dorsal raphe stimulation reduces centrally elicited fear like behavior. Brain Res., 191, 265–72.PubMedCrossRefGoogle Scholar
  29. Lista, A., Blier, P. and De Montigny, C. (1989). In vivo presynaptic modulation of serotonergic neurotransmission in the rat hippocampus by diazepam. Europ. J. Pharmacol., 171, 229–31.CrossRefGoogle Scholar
  30. Maltzman, I., Gould, J., Barnett, O. J., Raskin, D. C. and Wolff, C. (1979). Habituation of the GSR and digital vasomotor components of the orienting reflex as a consequence of task instructions and sex differences. Physiol. Psychol., 7, 213–20.CrossRefGoogle Scholar
  31. McNair, D. M. and Kahn, R. J. (1981). Imipramine compared with a benzodiazepine for agoraphobia. In Klein, D. F. and Rabkin, J. (eds.), Anxiety: New Research and Changing Concepts, Raven, New York, 69–80.Google Scholar
  32. Medical Research Council (1965). Clinical trial of the treatment of depressive illness. Br. Med. J., 2, 881–6.CrossRefGoogle Scholar
  33. Nashold, B. S., Jr, Wilson, W. P. and Slaughter, D. G. (1969). Sensations evoked by stimulation in the midbrain of man. J. Neurosurg., 30, 14–24.PubMedCrossRefGoogle Scholar
  34. Petersen, E. N. and Scheel-Krueger, J. (1984). Anticonflict effects of 5HT antagonists by intraamygdaloid injection. Collegium Internationale Neuro-Psychopharmacologicum, 14th CINP, congress book of abstracts, 654.Google Scholar
  35. Pitman, R. K. and Orr, S. P. (1986). Test of the conditioned model of neurosis: differential aversive conditioning of angry and neutral facial expressions in anxiety disorders patients. J. Abn. Psychol., 95, 208–13.CrossRefGoogle Scholar
  36. Sakurai-Yamashita, Y., Kataoka, Y., Yamashita, K., Miyazaki, A., Ushio, M., Mine, K., Niwa, M. and Ueki, S. (1989). Conflict behavior and dynamics of monoamines of various brain nuclei in rats. Neuropharmacol., 28, 1067–73.CrossRefGoogle Scholar
  37. Sano, K., Sekino, H. and Mayanagi, Y. (1972). Results of stimulation and destruction of posterior hippocampus in cases with violent, aggressive and restless behaviors. In Hitchcoch, E., Laitinen, L. and Vaernet, K. (eds.), Psychosurgery, Thomas, Springfield, 57.Google Scholar
  38. Schenberg, L. C. and Graeff, F. G. (1978). Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines. Pharmacol. Biochem. Behav., 9, 287–95.PubMedCrossRefGoogle Scholar
  39. Segal, M., Azmitia, E. C. and Whitaker-Azmitia, P. M. (1989). Physiological effects of selective 5HT1a and 5HT1b ligands in rat hippocampus: comparison to 5HT. Brain Res., 502, 67–74.PubMedCrossRefGoogle Scholar
  40. Shibata, K., Kataoka, Y., Yamashita, K. and Ueki, S. (1986). An important role of the central amygdaloid nucleus and mammilary body in the mediation of conflict behavior in rats. Brain Res., 372, 159–62.PubMedCrossRefGoogle Scholar
  41. Soubrie, P. (1986). Reconciling the role of central serotonin neurones in human and animal behaviour. Behav. Brain Sci., 9, 319–64.CrossRefGoogle Scholar
  42. Turner, B. H., Mislikin, M. and Knapp, M. (1980). Organization of the amygdalopetal projections from modality-specific cortical association areas in the monkey. J. Comp. Neurol., 191, 515–43.PubMedCrossRefGoogle Scholar
  43. Tye, N. C., Everitt, B. J. and Iversen, S. D. (1977). 5-hydroxytryptamine and punishment. Nature, 268, 741–3.PubMedCrossRefGoogle Scholar
  44. Wise, C. D., Berger, B. D. and Stein, L. (1972). Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the rat brain. Science, 17, 180–3.CrossRefGoogle Scholar

Copyright information

© Macmillan Publishers Limited 1991

Authors and Affiliations

  • J. F. W. Deakin
    • 1
  • F. S. Guimarães
  • M. Wang
  • J. Hellewell
  • R. Hensman
  1. 1.University Department of PsychiatryWithington HospitalManchesterUK

Personalised recommendations